Cargando…

Fibulin1 and mesothelin expressions in pancreas ductal adenocarcinoma

OBJECTIVE: The balance between malignant tumor cells and the connective tissue surrounding them determines the aggressiveness of the tumor. We aimed to understand the effects of mesothelin (MSLN) and fibulin1 (FBLN1) expressions on survival in pancreas ductal adenocarcinoma (PDCA), and also whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksoy, Asude, Artas, Gokhan, Kuloglu, Tuncay, Koc, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331239/ https://www.ncbi.nlm.nih.gov/pubmed/37435286 http://dx.doi.org/10.14744/nci.2022.49260

Ejemplares similares

Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer
por: Aksoy, Asude, et al.
Publicado: (2017)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

siRNA-mediated stathmin1 silencing inhibits proliferation of prostate carcinoma cell line
por: AKSOY, Asude, et al.
Publicado: (2022)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

A preliminary study: is fibulin 1 a friend or an enemy that needs to be silenced with siRNAs for mesothelioma?
por: Aksoy, Asude, et al.
Publicado: (2021)

Is there any difference between endometrial hyperplasia and endometrial carcinoma in terms of expression of TRPM2 and TRPM7 ion channels?
por: YALÇIN, Emre, et al.
Publicado: (2019)

Histoepigenetic analysis of the mesothelin network within pancreatic ductal adenocarcinoma cells reveals regulation of retinoic acid receptor gamma and AKT by mesothelin
por: Lurie, Eugene, et al.
Publicado: (2020)

Protective effects of vitamin C and vitamin E against hysterosalpingography-induced epithelial degeneration and proliferation in rat endometrium
por: Pala, Şehmus, et al.
Publicado: (2016)

Comparison of irisin hormone expression between thyroid cancer tissues and oncocytic variant cells
por: Ugur, Kader, et al.
Publicado: (2019)

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

(99m)Tc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2019)

Serum, Saliva, and Urine Irisin with and Without Acute Appendicitis and Abdominal Pain
por: Bakal, Unal, et al.
Publicado: (2016)

Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes
por: Han, Song-Hee, et al.
Publicado: (2017)

Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins.
por: Löhr, M., et al.
Publicado: (1994)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)

Protease‐activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma
por: Tekin, Cansu, et al.
Publicado: (2021)

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin
por: Snell, Daniel, et al.
Publicado: (2023)

Intraductal papillary mucinous neoplasm to pancreas ductal adenocarcinoma sequence and pancreas cancer screening
por: Farrell, James J.
Publicado: (2018)

Unusual presentation; seeding of tumor after biopsy for hepatocellular carcinoma
por: Aksoy, Asude, et al.
Publicado: (2016)

Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
por: Shin, Jaehoon, et al.
Publicado: (2020)

Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma
por: Baird, Brandi N., et al.
Publicado: (2013)

Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
por: Schnipper, Julie, et al.
Publicado: (2020)

CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas
por: D’Onofrio, Mirko, et al.
Publicado: (2021)

Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.
por: Suwa, H., et al.
Publicado: (1998)

Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
por: Ye, Lin, et al.
Publicado: (2019)

Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma
por: Kim, Hyunsung, et al.
Publicado: (2019)

Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants*
por: Fausther, Michel, et al.
Publicado: (2017)

Do mesothelin/MUC16 interactions facilitate adenocarcinoma metastases to intracranial meningiomas?
por: Johnson, Mahlon D.
Publicado: (2016)

Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer
por: Fukamachi, Katsumi, et al.
Publicado: (2014)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies
por: Moentenich, Valeska, et al.
Publicado: (2020)

Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
por: Skorupan, Nebojsa, et al.
Publicado: (2023)

The expression of Fibulin-3 in ovarian cancer and its relationship with prognosis
por: Wang, Xinmei, et al.
Publicado: (2020)

Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy
por: Safi, S. A., et al.
Publicado: (2021)

Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report
por: Frei, Lina, et al.
Publicado: (2017)

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
por: Yu, Yi, et al.
Publicado: (2011)

High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
por: Thomas, Anish, et al.
Publicado: (2015)

A Unicorn Disease: The Large Duct Variant of Invasive Ductal Adenocarcinoma of the Pancreas
por: Elhariri, Ahmed, et al.
Publicado: (2023)

Concurrent ductal adenocarcinoma, pseudocyst, and neuroendocrine tumor of the pancreas: A case report
por: Liu, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gk6iv4o6oa72ji5p4fjhj9okpf